Table of Contents
Introduction
Hypercholesterolemia- Overview
Hypercholesterolemia- Therapeutics Development
Hypercholesterolemia- Therapeutics Assessment
Hypercholesterolemia- Companies Involved in Therapeutics Development
Hypercholesterolemia- Drug Profiles
Hypercholesterolemia- Dormant Projects
Hypercholesterolemia- Discontinued Products
Hypercholesterolemia- Product Development Milestones
Appendix

List of Tables
Number of Products under Development for Hypercholesterolemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Hypercholesterolemia - Pipeline by 3SBio Inc, H2 2020
Hypercholesterolemia - Pipeline by AD Pharmaceuticals Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by Akcea Therapeutics Inc, H2 2020
Hypercholesterolemia - Pipeline by Alexion Pharmaceuticals Inc, H2 2020
Hypercholesterolemia - Pipeline by Amgen Inc, H2 2020
Hypercholesterolemia - Pipeline by Amryt Pharma Plc, H2 2020
Hypercholesterolemia - Pipeline by Arrowhead Pharmaceuticals Inc, H2 2020
Hypercholesterolemia - Pipeline by Astellas Pharma Inc, H2 2020
Hypercholesterolemia - Pipeline by AstraZeneca Plc, H2 2020
Hypercholesterolemia - Pipeline by Beijing Mabworks Biotech Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by BioLingus AG, H2 2020
Hypercholesterolemia - Pipeline by CardioPharma Inc, H2 2020
Hypercholesterolemia - Pipeline by Centeer BioTherapeutics Ltd Co, H2 2020
Hypercholesterolemia - Pipeline by Chong Kun Dang Pharmaceutical Corp, H2 2020
Hypercholesterolemia - Pipeline by Civi Biopharma Inc, H2 2020
Hypercholesterolemia - Pipeline by Cumberland Pharmaceuticals Inc, H2 2020
Hypercholesterolemia - Pipeline by Daewoong Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by Delivra Corp, H2 2020
Hypercholesterolemia - Pipeline by Dogma Therapeutics Inc, H2 2020
Hypercholesterolemia - Pipeline by Draupnir Bio Aps, H2 2020
Hypercholesterolemia - Pipeline by Eight Plus One Pharmaceutical Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by Golden Biotechnology Corp, H2 2020
Hypercholesterolemia - Pipeline by Gruthan Bioscience LLC, H2 2020
Hypercholesterolemia - Pipeline by Guangzhou Jiayue Pharmaceutical Technology Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by Hingez Therapeutics Inc, H2 2020
Hypercholesterolemia - Pipeline by Innovent Biologics Inc, H2 2020
Hypercholesterolemia - Pipeline by Jiangsu Carephar Pharmaceutical Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by Jiangsu Hengrui Medicine Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by JW Pharmaceutical Corp, H2 2020
Hypercholesterolemia - Pipeline by Kadmon Corp LLC, H2 2020
Hypercholesterolemia - Pipeline by Kowa Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by Kyorin Pharmaceutical Co Ltd, H2 2020
Hypercholesterolemia - Pipeline by LIB Therapeutics LLC, H2 2020
Hypercholesterolemia - Pipeline by Lipigon Pharmaceuticals AB, H2 2020
Hypercholesterolemia - Pipeline by LipimetiX Development Inc, H2 2020
Hypercholesterolemia - Pipeline by Luye Pharma Group Ltd, H2 2020
Hypercholesterolemia - Pipeline by Lyndra Therapeutics Inc., H2 2020
Hypercholesterolemia - Pipeline by Madrigal Pharmaceuticals Inc, H2 2020
Hypercholesterolemia - Pipeline by Medlab Clinical Ltd, H2 2020
Hypercholesterolemia - Dormant Projects, H2 2020
Hypercholesterolemia - Discontinued Products, H2 2020

List of Figures
Number of Products under Development for Hypercholesterolemia, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020

Companies Mentioned
• 3SBio Inc
• AD Pharmaceuticals Co Ltd
• Akcea Therapeutics Inc
• Alexion Pharmaceuticals Inc
• Amgen Inc
• Amryt Pharma Plc
• Arrowhead Pharmaceuticals Inc
• Astellas Pharma Inc
• AstraZeneca Plc
• Beijing Mabworks Biotech Co Ltd
• BioLingus AG
• CardioPharma Inc
• Centeer BioTherapeutics Ltd Co
• Chong Kun Dang Pharmaceutical Corp
• Civi Biopharma Inc
• Cumberland Pharmaceuticals Inc
• Daewoong Co Ltd
• Delivra Corp
• Dogma Therapeutics Inc
• Draupnir Bio Aps
• Eight Plus One Pharmaceutical Co Ltd
• Golden Biotechnology Corp
• Gruthan Bioscience LLC
• Guangzhou Jiayue Pharmaceutical Technology Co Ltd
• Hingez Therapeutics Inc
• Innovent Biologics Inc
• Jiangsu Carephar Pharmaceutical Co Ltd
• Jiangsu Hengrui Medicine Co Ltd
• JW Pharmaceutical Corp
• Kadmon Corp LLC
• Kowa Co Ltd
• Kyorin Pharmaceutical Co Ltd
• LIB Therapeutics LLC
• Lipigon Pharmaceuticals AB
• LipimetiX Development Inc
• Luye Pharma Group Ltd
• Lyndra Therapeutics Inc.
• Madrigal Pharmaceuticals Inc
• Medlab Clinical Ltd
• NeuroBo Pharmaceuticals Inc
• Novartis AG
• Novo Nordisk AS
• Nyrada Inc
• OliPass Corporation
• Pfizer Inc
• Precision Biosciences Inc
• Progenra Inc
• Regeneron Pharmaceuticals Inc
• Repair Biotechnologies Inc
• Sanofi
• Shanghai Henlius Biotech Inc
• Shanghai Junshi Bioscience Co Ltd
• Shenzhen HighTide Biopharmaceutical Ltd
• Shenzhen Salubris Pharmaceuticals Co Ltd
• Shifa Biomedical Corp
• Viking Therapeutics Inc
• Zhejiang Hisun Pharmaceutical Co Ltd
• Zhejiang Teruisi Pharmaceutical Co Ltd